Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Peter Norman. (2014) Pulmonary arterial hypertension: a rare disease that encourages the development of multiple treatments. Expert Opinion on Orphan Drugs 2:11, pages 1137-1145.
Read now
Read now
Mark J Schuuring, Jeroen C Vis, Marielle G Duffels, Berto J Bouma & Barbara JM Mulder. (2010) Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan. Therapeutics and Clinical Risk Management 6, pages 359-366.
Read now
Read now
Articles from other publishers (24)
Shraddha Narechania & Mark A. Malesker. (2022) Drug Interactions Associated With Therapies for Pulmonary Arterial Hypertension. Journal of Pharmacy Technology 38:6, pages 349-359.
Crossref
Crossref
Stephanie Lua & Colin Church. (2022) Pulmonary hypertension in the primary care setting. Prescriber 33:11-12, pages 11-18.
Crossref
Crossref
Devis Benfaremo, Silvia Svegliati, Chiara Paolini, Silvia Agarbati & Gianluca Moroncini. (2022) Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 10:1, pages 163.
Crossref
Crossref
Massimiliano Mulè, Giulia Passaniti & Daniela Giannazzo. 2022. Cardiovascular Diseases [Working Title]. Cardiovascular Diseases [Working Title].
Andrew D. Franklin, Bimal P. Chaudhari, Daniel C. Koboldt & Kerri Z. Machut. (2021) Polymerase Gamma Mitochondrial DNA Depletion Syndrome Initially Presenting as Disproportionate Respiratory Distress in a Moderately Premature Neonate: A Case Report. Frontiers in Genetics 12.
Crossref
Crossref
Fatemeh Afra, Marjan Mehri & Soha Namazi. (2021) Bosentan-induced immune hemolytic anemia in 17 years old man. A case report. DARU Journal of Pharmaceutical Sciences 29:1, pages 211-215.
Crossref
Crossref
. (2020) Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions. Obstetrics & Gynecology 136:5, pages e90-e99.
Crossref
Crossref
Mohammad Khani, Maryam Hamidzad, Fariba Bayat, MortezaAbdar Esfahani, Fatemeh Saffarian, Hooman Bakhshande & SeyedMehdi Talebzade. (2020) 2D Speckel Tracking of RV Function after CABG and CPB Time. Research in Cardiovascular Medicine 9:4, pages 77.
Crossref
Crossref
Matthias BartonMasashi Yanagisawa. (2019) Endothelin: 30 Years From Discovery to Therapy. Hypertension 74:6, pages 1232-1265.
Crossref
Crossref
Virna M. Giménez, Norma Sperandeo, Sonia Faudone, Sandra Noriega, Walter Manucha & Diego Kassuha. (2018) Preparation and characterization of bosentan monohydrate/ε‐polycaprolactone nanoparticles obtained by electrospraying. Biotechnology Progress 35:2, pages e2748.
Crossref
Crossref
Lillian Hansen, Marsha Burks, Martha Kingman & Traci Stewart. (2018) Volume Management in Pulmonary Arterial Hypertension Patients: An Expert Pulmonary Hypertension Clinician Perspective. Pulmonary Therapy 4:1, pages 13-27.
Crossref
Crossref
Bahare Fazeli, Maliheh Dadgar Moghadam & Shabnam Niroumand. (2018) How to Treat a Patient with Thromboangiitis Obliterans: A Systematic Review. Annals of Vascular Surgery 49, pages 219-228.
Crossref
Crossref
Joseph E. Jacher, Lisa J. Martin, Wendy K. Chung, James E. Loyd & William C. Nichols. (2017) Pulmonary arterial hypertension: Specialists’ knowledge, practices, and attitudes of genetic counseling and genetic testing in the USA. Pulmonary Circulation 7:2, pages 372-383.
Crossref
Crossref
Y. Huo, Z. C. Jing, X. F. Zeng, J. M. Liu, Z. X. Yu, G. C. Zhang, Y. Li, Y. Wang, Q. S. Ji, P. Zhu, B. X. Wu, Y. Zheng, P. P. Wang & J. Li. (2016) Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study. BMC Cardiovascular Disorders 16:1.
Crossref
Crossref
C.R. Mejía Chew, S.A. Batres & J.J. Ríos Blanco. (2016) Update on pulmonary arterial hypertension. Revista Clínica Española (English Edition) 216:8, pages 436-444.
Crossref
Crossref
C.R. Mejía Chew, S. Alcolea Batres & J.J. Ríos Blanco. (2016) Actualización en hipertensión arterial pulmonar. Revista Clínica Española 216:8, pages 436-444.
Crossref
Crossref
Shane J. LaRue, Rafael Garcia-Cortes, Michael E. Nassif, Justin M. Vader, Shuddhadeb Ray, Ashwin Ravichandran, Ravi Rasalingham, Scott C. Silvestry, Gregory A. Ewald, I-Wen Wang & Joel D. Schilling. (2015) Treatment of Secondary Pulmonary Hypertension with Bosentan after Left Ventricular Assist Device Implantation. Cardiovascular Therapeutics 33:2, pages 50-55.
Crossref
Crossref
V. V. Bystrov, O. A. Arkhipova, T. V. Martynyuk, M. A. Saidova, O. V. Stukalova, N. M. Danilov, T. A. Sakhnova & I. Ye. Chazova. (2014) CLINICAL CASE: COMBINATION THERAPY WITH BOSENTAN AND SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION. Eurasian heart journal:4, pages 26-33.
Crossref
Crossref
Hiroki Saitsu, Osuke Iwata, Junichiro Okada, Akiko Hirose, Hiroshi Kanda, Toyojiro Matsuishi, Kenji Suda & Yasuki Maeno. (2013) Refractory pulmonary hypertension following extremely preterm birth: paradoxical improvement in oxygenation after atrial septostomy. European Journal of Pediatrics 173:11, pages 1537-1540.
Crossref
Crossref
Adrian H. Chester & Magdi H. Yacoub. (2014) The role of endothelin-1 in pulmonary arterial hypertension. Global Cardiology Science and Practice 2014:2, pages 29.
Crossref
Crossref
Mark J. Schuuring, Pauline P. M. Bolmers, Barbara J. M. Mulder, Rianne A. C. M. de Bruin-Bon, Dave R. Koolbergen, Mark G. Hazekamp, Wim K. Lagrand, Stefan G. De Hert, E. M. F. H. de Beaumont & Berto J. Bouma. (2011) Right ventricular function declines after cardiac surgery in adult patients with congenital heart disease. The International Journal of Cardiovascular Imaging 28:4, pages 755-762.
Crossref
Crossref
Sedigheh Khastkhodaei, Gholamreza Sharifi, Reza Salahi, Mohammad Rahnamaeian & Fariborz Moattar. (2011) Clinical efficacy of Stragol™ herbal heart drop in ischemic heart failure of stable chest angina. European Journal of Integrative Medicine 3:3, pages e201-e207.
Crossref
Crossref
Yifang Mei, Hong Jin, Wei Tian, Hao Wang, Han Wang, Yanping Zhao, Zhiyi Zhang & Fanchao Meng. (2011) Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats. Pulmonary Pharmacology & Therapeutics 24:4, pages 386-393.
Crossref
Crossref
Lynette M. Brown, Hubert Chen, Scott Halpern, Darren Taichman, Michael D. McGoon, Harrison W. Farber, Adaani E. Frost, Theodore G. Liou, Michelle Turner, Kathy Feldkircher, Dave P. Miller & C. Gregory Elliott. (2011) Delay in Recognition of Pulmonary Arterial Hypertension. Chest 140:1, pages 19-26.
Crossref
Crossref